Company ProfilePremium

ALLIANCE PHARMA PLC

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
ALLIANCE PHARMA PLC - Healthcare showcase

Year Founded & Workforce

1998

210 Employees

Industry

Healthcare

Services

Eye Supplement
A

ALLIANCE PHARMA PLC Employee Contacts

3 verified contactsNames, job titles, seniority and locations

View Employee Contacts

ALLIANCE PHARMA PLC Overview

Company Headquarters: Wiltshire, England, UK

Founded: 1998

Workforce: 210

Company Working: Alliance Pharma PLC is a specialty pharmaceutical company with a strong track record of acquiring the rights to established niche products and owns or licenses the rights to more than 60 pharmaceutical products currently. In 2015, the company acquired MacuVision Europe Limited for an initial consideration of EUR 5.5 million (USD 7.15 million). MacuVision is into selling MacuShield, an eye care treatment designed to be taken by sufferers of dry age-related macular degeneration and other eye conditions. The company distributes its products through wholesalers, retail pharmacies, hospitals and renowned international network of distributors. It has offices in Paris, Milan, Madrid, Düsseldorf, Dublin, Shanghai, and Singapore, in addition to its headquarter in England.

Strategy

Alliance Pharma PLC develops technologies and solutions in line with its mission to restore health and extended life for people. The company focuses on value-based healthcare principles to drive global growth. It also focuses on partnerships to increase its presence and improve clinical and economic outcomes across its therapeutic areas. It also focuses on expanding its presence in various regions through mergers and acquisitions.

Company Snapshot

$126.6M

Revenue

210

Employees

1998

Founded

Wiltshire, England, UK

Headquarters

SWOT Analysis

Strengths

  • Strong supply chain network, along with distributor network
  • Strong workforce
  • Strong marketing strategies
  • Acquisition and licensing of pharmaceutical and healthcare products

Weaknesses

  • Increased production costs

Opportunities

  • Expanding the innovation map beyond the established product portfolio
  • New products and new markets

Threats

  • Intense rivalry with other key players in the market
  • Currency fluctuations

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Product Offering

  • ALLIANCE PHARMA PLC
    • Eye Supplement

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Sales rose from USD 126.6 Mn in 2016 to USD 165.3 Mn in 2018.
ALLIANCE PHARMA PLC — By Business Segment
Series (USD Mn)201620172018
Sales126.6125.7165.3

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.